Cargando…
Dose intensity analysis in advanced ovarian cancer patients.
To determine if chemotherapy dose intensity influences treatment outcome in advanced ovarian cancer, all randomised studies of first line chemotherapy, published between 1975 and 1989, were analysed for relationships between planned dose intensity and (a) objective response and (b) median survival....
Autores principales: | Torri, V., Korn, E. L., Simon, R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968241/ https://www.ncbi.nlm.nih.gov/pubmed/8427779 |
Ejemplares similares
-
First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence.
por: Sandercock, J., et al.
Publicado: (1998) -
First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence
por: Sandercock, J, et al.
Publicado: (2002) -
High dose, dose-intensive chemotherapy with doxorubicin and cyclophosphamide for the treatment of advanced breast cancer.
por: Ferguson, J. E., et al.
Publicado: (1993) -
High dose intensity combination chemotherapy for advanced epithelial ovarian carcinoma: results of a pilot study.
por: Sweetenham, J. W., et al.
Publicado: (1990) -
Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG)).
por: Marsoni, S., et al.
Publicado: (1990)